14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:GNCA
Delisted

Genocea Biosciences Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$0.0001
+0 (+0%)
At Close: Apr 19, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0001 $0.0001 Wednesday, 19th Apr 2023 GNCA stock ended at $0.0001. During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001.
90 days $0.0001 $0.0001
52 weeks $0.0001 $0.469

Historical Genocea Biosciences prices

Date Open High Low Close Volume
May 25, 2022 $0.0909 $0.0988 $0.0675 $0.0920 177 710 953
May 24, 2022 $0.0700 $0.0840 $0.0590 $0.0609 75 011 081
May 23, 2022 $0.210 $0.229 $0.210 $0.223 436 692
May 20, 2022 $0.230 $0.240 $0.200 $0.209 583 274
May 19, 2022 $0.239 $0.246 $0.215 $0.220 637 946
May 18, 2022 $0.218 $0.245 $0.215 $0.242 1 074 676
May 17, 2022 $0.222 $0.240 $0.200 $0.225 1 142 602
May 16, 2022 $0.241 $0.253 $0.215 $0.215 3 312 596
May 13, 2022 $0.182 $0.350 $0.180 $0.225 19 270 771
May 12, 2022 $0.163 $0.178 $0.160 $0.168 1 430 425
May 11, 2022 $0.190 $0.190 $0.161 $0.170 1 197 988
May 10, 2022 $0.200 $0.220 $0.180 $0.184 2 034 348
May 09, 2022 $0.210 $0.217 $0.195 $0.198 778 557
May 06, 2022 $0.230 $0.240 $0.220 $0.224 563 620
May 05, 2022 $0.270 $0.270 $0.242 $0.244 1 636 271
May 04, 2022 $0.268 $0.268 $0.251 $0.259 674 337
May 03, 2022 $0.280 $0.280 $0.251 $0.266 1 122 744
May 02, 2022 $0.280 $0.280 $0.257 $0.273 1 298 955
Apr 29, 2022 $0.275 $0.321 $0.268 $0.283 3 293 503
Apr 28, 2022 $0.420 $0.420 $0.390 $0.408 1 050 017
Apr 27, 2022 $0.373 $0.420 $0.370 $0.410 935 329
Apr 26, 2022 $0.375 $0.419 $0.350 $0.385 1 509 716
Apr 25, 2022 $0.406 $0.406 $0.304 $0.375 1 982 914
Apr 22, 2022 $0.418 $0.467 $0.400 $0.418 830 500
Apr 21, 2022 $0.446 $0.469 $0.416 $0.421 1 576 400
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 11.73% $52.28
LPLA Apr 19 1.08% $262.59
DOOR Apr 18 0.274% $131.39
LNG Apr 17 1.63% $156.81
FCN Apr 16 3.70% $207.62
ELV Apr 16 6.45% $506.97
AKR Apr 05 5.14% $16.53
ITCI Apr 05 5.39% $68.44
SARK Mar 28 14.47% $26.88
ARCC Mar 25 2.53% $20.12
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT